Indivior Pharmaceuticals Inc (INDV)
Cost of Revenue
$215.00M
TTM · Period ending: · USD
INDV Cost of Revenue
Latest reported$215.00Mperiod ending
Latest reported$215.00Mperiod ending
INDV TTM Cost of Revenue ($154.00M → $215.00M)
TTM cost of revenue
High-resolution chart · PNG
INDV cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 214,999,999 | |
| 217,999,999 | |
| 222,000,000 | |
| 181,000,000 | |
| 188,000,000 | |
| 215,000,000 | |
| 209,000,000 | |
| 237,000,000 | |
| 214,000,000 | |
| 185,000,000 | |
| 186,000,000 | |
| 179,000,000 | |
| 173,000,000 | |
| 161,000,000 | |
| 159,000,000 | |
| 154,000,000 |